Jim Cramer - Mad Money AbCellera Biologics ABCL-Q RISKY Sep 22, 2021

It's a spec play, but he likes the biologics space.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$21.340

Stock price when the opinion was issued

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

This biotech is purely speculative. He ain't playin'.

COMMENT

They're okay. Shares have fallen, but the company makes money.

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

Joe Terranova

Virtus Investment Partners

Jim Lebenthal

Cerity Partners

Shannon Saccocia, CIO, Boston Private

Boston Private

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money AbCellera Biologics ABCL-Q RISKY Sep 22, 2021

You might be interested:

AbCellera Biologics(ABCL-Q)

AbCellera Biologics(ABCL-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals